Device profile of the Bonebridge bone conduction implant system in hearing loss: an overview of its safety and efficacy

ABSTRACT

Introduction

The Bonebridge is an active transcutaneous semi-implantable bone conduction hearing device suitable for several types of hearing loss. It has unique benefits over some more established technologies. It consists of an internal active implant and an external sound processor. It was first launched in 2012, with a newer model released in late 2019.

Areas covered

The structure and features of the device are described. Indications, audiological criteria, and contraindications to implantation are discussed. The planning and procedure of implantation surgery are also described. Research outlining the outcomes of implant use and risk of adverse events is highlighted.

Expert opinion

The evidence included in this article demonstrates the successful audiological outcomes and patient satisfaction with Bonebridge implantation. The rate of adverse events following surgery is low and compares well with other devices which may be considered for Bonebridge candidates. The device should be considered as an option for suitable candidates and in many cases may be the better option available, given the low incidence of skin complications and the absence of a skin penetrating abutment. Future advances are likely to affect sound processor technology, connectivity, and possibly further reduction in implant size and gain.

KEYWORDS:

• Bone conduction
• hearing aids
• hearing loss
• prostheses and implants

Article highlights

• The Bonebridge hearing implant is currently a unique device on the market.

• The device is suitable for a significant range of hearing losses.

• Audiological testing demonstrates good outcomes.

• Patient satisfaction with the device is positive.

• The rate of severe adverse events is low and compares favorably with alternative devices.

Declaration of interest

Med-El UK funded the colour publication of the figures in this manuscript. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Reviewer disclosures

Peer reviewers on this manuscript have no relevant financial or other relationships to disclose.

Information resources

Med-El company website Bonebridge section for professionals: https://www.medel.com/products-bonebridge/

Additional information

Funding

This paper was partially funded by MED-EL.